维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="Guba SC"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	Hyperhomocysteinemia-an emerging and important risk factor for thromboembolic and cardiovascular disease显示文摘	Guba SC Fink LM Fonseca V	1996	Am J Clin Chem Pathol1996，106，6：	1
2	Hyperhomocysteinemia andthrombosis显示文摘	Guba SC Fonseca V Fink LM	1999	Semin Thromb Hemost1999，25，3：	1
3	Hyperhomocysteinemia and thrombosis 显示文摘	Guba SC Fonseca V Fink LM	1999	Semin Thromb Hemost1999，25，3：	1
4	Hyperhomocysteinemia and thrombosis显示文摘	Guba SC Fonseca V Fink LM	1999	Semin Thromb Hemost1999，25，：	1
5	Hyper-homoeysteinemia and pre- mature vascular occlusive disease显示文摘	Guba SC Fink LM Fonseca V	1998	Am J Med Sci1998，315，4：	1
6	Bone marrow stromal fibroblasts secrete interleukin-6 and granulocyte- macrophage colony-stimulating factor in the absence of inflammatory stimulation: demonstration by serum-free bioassay, enzyme-linked immunosorbent assay, and reverse transcriptase polymerase chain reaction 显示文摘	Guba SC Gottschalk LR Sartor CI etal	1992	Blood1992，80，：	1
7	Regulation of interleukin-3 gene induction in normal human T cell显示文摘	Guba SC Stella G Turka LA	1989	J Clin Invest1989，84，：	1
8	Hyperhomo- cysteinemia, an emerging and important risk factor for thromembolic and cardiovascular dis- ease 显示文摘	Guba SC Fink LM Fonesca V		AmJ Clin Pathol0，106，6：	1
9	Hyperhomocysteinemia: An emerging and important risk factor for thromboembolic and cardiovascular dis- ease 显示文摘	Guba SC Fink LM Fonseca V	1996	Am Clin Pathol1996，106，6：	1
10	Hyperhomocysteinemia,an emer-ging and important risk factor for thromembolic and cardiovasculardisease显示文摘	Guba SC Fink LM Fonesca V	1996	Am J Clin Pathol1996，106，6：	1
11	Hyperhomocystinemina, a emerging and important risk factor for thromoembolic And cardiovascular disease显示文摘	Guba SC Fink LMs Gonesca V	1996	AM JClin Pathol1996，106，：	1
12	Hyperhomocysteinemia and the endocrine system: implications for atherosclerosis and thrombosis显示文摘	Fonseca V Guba SC Fink LM	1999	Endocr Rev1999，20，10：	1
13	Hyperhomocysteinemia, an factor for thromembolic and cardiovascular disease显示文摘	Guba SC Fink LM Fonesca emerging and important risk V	1996	Am J Clin Pathol1996，106，6：	1
14	Hyperhomocysteinemia and the endocrine system:implication for atherosclerosis and thrombosis显示文摘	Fonseca V Guba SC Fink LM	1999	Endocrine Rev1999，20，：	1
15	Hyperhomocysteinemia an emerging and important risk factor for thromboembolic and cardiovascular disease显示文摘	Fink LM Fonseca V	1996	Am J Clin pathol1996，106，6：	1
16	An emerging and impor- tant risk factor for thromembolic and cardiovascular disease 显示文摘	Guba SC Fink LM Hyperhomocysteinemia FV	1996	Am J Clin Pathol1996，106，6：	1
17	Hyperhomocysteinemia, an emerging and important risk factor for thromboembolic and cardiovascular disease 显示文摘	Guba SC Fink LM Fonseca V	1996	Am J Clin Pathol1996，106，6：	1
18	Hyper homocysteinemia, an emerging and important risk for thromboembolic and cardiovascular disease 显示文摘	Guba SC Fink LM Fonseca V	1996	Am J Clin Pathol1996，106，6：	1
19	Treatment rationale and study de-sign for the pointbreak study:a randomized,open-label phase III study of pemetrexed/carboplatin/bevacizumab followed by mainte-nance pemetrexed/bevacizumab versus paclitaxel/carboplatin/bevaci-zumab followed by maintenance bevacizumab in patients with stage II-IB or IV nonsquamous non-small-cell lung cancer显示文摘	Patel JD Bonomi P Socinski MA Govindan R Hong S Obasaju C Pennella EJ Girvan AC Guba SC	2009	Clin Lung Cancer2009，10，4：	1
20	Hyperhomocysteinemia: An emerging and important risk factor for thromboembolic and cardiovascular disease显示文摘	Guba SC Fink LM Fonseca V	1996	Am J Clin Pathol1996，105，5：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示